Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Dean

Showing results (71-80 of 248) with videos related to

Pageof 25
Sort By:
Journal of Neuroscience Methods|June 5, 2002
High-resolution phosphor imaging: validation for use with human brain tissue sections to determine the affinity and density of radioligand bindingGeoffrey M Pavey, David L Copolov, Brian Dean
Experimental Brain Research|January 22, 2020
Associations between catechol-O-methyltransferase (COMT) genotypes at rs4818 and rs4680 and gene expression in human dorsolateral prefrontal cortexBrian Dean, Georgia M Parkin, Andrew S Gibbons
Biomedical Chromatography : BMC|October 17, 2023
Matrix effect in bioanalytical assay development using supercritical fluid chromatography-mass spectrometryLiuxi Chen, Yuxiang Cui, Brian Dean, et al.
Journal of Affective Disorders|June 5, 2003
Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorderBrian Dean, Elizabeth Scarr, Geoffrey Pavey, et al.
Life Sciences|October 11, 2005
No change in cortical muscarinic M2, M3 receptors or [35S]GTPgammaS binding in schizophreniaElizabeth Scarr, Dahlia Keriakous, Nicola Crossland, et al.
Brain Research|January 30, 2002
[(3)H]Flumazenil binding in the human hippocampal formation, frontal cortex and cerebellum detected by high-resolution phosphorimagingMark McLeod, Daniele Pralong, David Copolov, et al.
Schizophrenia Research|October 8, 2010
Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophreniaAdel Barakat, Brian Dean, Elizabeth Scarr, et al.
Schizophrenia Research|October 12, 2004
GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patientsCarmit Nadri, Brian Dean, Elizabeth Scarr, et al.
Schizophrenia Research|August 12, 2008
Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophreniaBrian Dean, Nicola Crossland, Simone Boer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 22, 2013
The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disordersWon Je Jeon, Andrew S Gibbons, Brian Dean
Pageof 25

Showing results (71-80 of 248) with videos related to

Sort By:
Pageof 25
Journal of Neuroscience Methods|June 5, 2002
High-resolution phosphor imaging: validation for use with human brain tissue sections to determine the affinity and density of radioligand bindingGeoffrey M Pavey, David L Copolov, Brian Dean
Experimental Brain Research|January 22, 2020
Associations between catechol-O-methyltransferase (COMT) genotypes at rs4818 and rs4680 and gene expression in human dorsolateral prefrontal cortexBrian Dean, Georgia M Parkin, Andrew S Gibbons
Biomedical Chromatography : BMC|October 17, 2023
Matrix effect in bioanalytical assay development using supercritical fluid chromatography-mass spectrometryLiuxi Chen, Yuxiang Cui, Brian Dean, et al.
Journal of Affective Disorders|June 5, 2003
Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorderBrian Dean, Elizabeth Scarr, Geoffrey Pavey, et al.
Life Sciences|October 11, 2005
No change in cortical muscarinic M2, M3 receptors or [35S]GTPgammaS binding in schizophreniaElizabeth Scarr, Dahlia Keriakous, Nicola Crossland, et al.
Brain Research|January 30, 2002
[(3)H]Flumazenil binding in the human hippocampal formation, frontal cortex and cerebellum detected by high-resolution phosphorimagingMark McLeod, Daniele Pralong, David Copolov, et al.
Schizophrenia Research|October 8, 2010
Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophreniaAdel Barakat, Brian Dean, Elizabeth Scarr, et al.
Schizophrenia Research|October 12, 2004
GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patientsCarmit Nadri, Brian Dean, Elizabeth Scarr, et al.
Schizophrenia Research|August 12, 2008
Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophreniaBrian Dean, Nicola Crossland, Simone Boer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 22, 2013
The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disordersWon Je Jeon, Andrew S Gibbons, Brian Dean
Pageof 25